🧬 Scientific summary of vitamin B3 and its role in fighting deadly brain cancer
The latest research indicates that vitamin B3 (niacin) may help enhance the immune system’s ability to fight the tumor glioblastoma, which is one of the most dangerous types of brain cancer. A new clinical trial showed that treatment supplemented with vitamin B3 achieved a 28% improvement in the rate of patients remaining free of cancer progression over six months, compared with previous studies. The study is trying to reactivate immune cells that this cancer suppresses in order to improve the effectiveness of conventional treatments.
🧠 What is glioblastoma and why is it such a major health challenge?
Glioblastoma is one of the most aggressive and dangerous types of brain cancer, and it affects neural tissue rapidly and extensively. It is difficult to treat because of the nature of the tumor, which usually makes surgery and radiation and chemotherapy insufficient to prevent its return.
Patients suffer from increasing symptoms such as constant fatigue and changes in movement, as happened with patient Ed Waldner (Ed Waldner), who noticed symptoms before being diagnosed with cancer.
🧪 A trial combining vitamin B3 with conventional treatments
A research team at the University of Calgary led by Dr. Gloria Roldan Urguiti and Dr. Wei Young is evaluating the ability of high doses of niacin (vitamin B3) to support the immune system in confronting glioblastoma.
The study is based on:
- Stimulating immune cells suppressed by the tumor so they regain their normal activity.
- Assessing the safety of using high doses of niacin alongside chemotherapy and radiation therapy.
- Measuring the effect of the new treatment using indicators such as progression-free survival at six months.
How vitamin B3 works on the immune system
The lack of immune effectiveness in glioblastoma patients is due to the tumor’s ability to suppress immune system cells. Laboratory results indicate that niacin reactivates these cells so they can attack tumor cells more effectively.
Researcher Wei Young described this struggle as a “continuous battle for the brain” between immune cells and cancer cells, and expects niacin to strengthen this defensive side.
🩺 Promising early results and safety warnings
In the study that involved 24 patients, the results showed that 82% of them did not experience cancer progression after six months of treatment with the niacin and conventional-treatment combination. This represents a 28% improvement compared with previous studies that focused on conventional treatments only.
Despite these encouraging results, researchers warn that taking high doses of vitamins such as niacin may be toxic if it is not done under careful medical supervision, highlighting the importance of completing research and clinical testing before broader use.
Future steps in the research
The study is ongoing and is planned to reach 48 participants by the end of 2026 or the beginning of 2027 for more precise final analyses. The financial support came from specialized Canadian institutes, reflecting the seriousness of the research and the possibility of translating the results of these trials into new treatment options.
🌱 Patient experiences and the impact of treatment
In the case of Ed Waldner, who took part in the study, feelings of fatigue and exhaustion dominated at first, but today he expresses satisfaction because of his relative health stability after the operation and continued treatment. The psychological success of participating in the research had a positive effect on him, as he felt hope and optimism despite the difficult diagnosis.
These stories reflect the importance of scientific research and clinical trials in confronting complex diseases such as glioblastoma, and in searching for innovative treatments that support cell glucose and help the immune system.
🧬 Conclusion: vitamin B3 as a potential adjunct in treating brain cancer
The study of vitamin B3 participation in treating glioblastoma opens new horizons that may change the course of patients suffering from this type of tumor. The preliminary results show that stimulating the immune system with vitamin B3 works to:
- Increase the rate of survival without disease progression.
- Enhance the ability of immune cells to attack the tumor.
- Provide a distinctive treatment option alongside conventional methods.
However, confirming dose safety and monitoring side effects remains a critical requirement. Future research will determine the extent to which this approach can be introduced into approved treatment protocols in the near future.
📚 Related articles
Discover more from Mohdbali
Subscribe to get the latest posts sent to your email.
